Page 13 - 2022-06-中国全科医学

·650· http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn

7141.2009.00058.x. 69-77. DOI：10.1002/ejhf.657.
［39］TERADA T，JOHNSON J A，NORRIS C，et al. Severe obesity ［51］VIEIRA J L，MEHRA M R. Dapagliflozin in patients with heart
is associated with increased risk of early complications and failure and reduced ejection fraction［J］. N Engl J Med，2020，
extended length of stay following coronary artery bypass grafting 382（10）：972-973. DOI：10.1056/NEJMc1917241.
surgery［J］. J Am Heart Assoc，2016，5（6）：e003282. ［52］RODRIGUEZ FLORES M，AGUILAR SALINAS C，PICHÉ M
DOI：10.1161/jaha.116.003282. E，et al. Effect of bariatric surgery on heart failure［J］. Expert
［40］WAGNER B D，GRUNWALD G K，RUMSFELD J S，et al. Rev Cardiovasc Ther，2017，15（8）：567-579. DOI：
Relationship of body mass index with outcomes after coronary artery 10.1080/14779072.2017.1352471.
bypass graft surgery［J］. Ann Thorac Surg，2007，84（1）： ［53］KOSHINO Y，VILLARRAGA H R，SOMERS V K，et al. Changes
10-16. DOI：10.1016/j.athoracsur.2007.03.017. in myocardial mechanics in patients with obesity following major
［41］CHASSÉ M，MATHIEU P，VOISINE P，et al. The underestimated weight loss after bariatric surgery［J］. Obesity，2013，21（6）：
belly factor：waist circumference is linked to significant morbidity 1111-1118. DOI：10.1002/oby.20168.
following isolated coronary artery bypass grafting［J］. Can ［54］SHIMADA Y J，TSUGAWA Y，BROWN D F M，et al. Bariatric
J Cardiol，2016，32（3）：327-335. DOI：10.1016/j. surgery and emergency department visits and hospitalizations for
cjca.2015.06.031. heart failure exacerbation：population-based，self-controlled
［42］CHIEN S C，CHANDRAMOULI C，LO C I，et al. Associations of series［J］. J Am Coll Cardiol，2016，67（8）：895-903.
obesity and malnutrition with cardiac remodeling and cardiovascular DOI：10.1016/j.jacc.2015.12.016.
outcomes in Asian adults：a cohort study［J］. PLoS Med，2021， ［55］LAVIE C J，MEHRA M R，VENTURA H O. Body composition
18（6）：e1003661. DOI：10.1371/journal.pmed.1003661. and advanced heart failure therapy：weighing the options and
［43］HORWICH T B，FONAROW G C，CLARK A L. Obesity and the outcomes［J］. JACC：Heart Fail，2016，4（10）：769-771.
obesity paradox in heart failure［J］. Prog Cardiovasc Dis，2018， DOI：10.1016/j.jchf.2016.07.007.
61（2）：151-156. DOI：10.1016/j.pcad.2018.05.005. ［56］AUNE D，SCHLESINGER S，NORAT T，et al. Body mass
［44］PANDEY A，PATEL K V，VADUGANATHAN M，et al. Physical index，abdominal fatness，and the risk of sudden cardiac death：
activity，fitness，and obesity in heart failure with preserved ejection a systematic review and dose-response meta-analysis of prospective
fraction［J］. JACC Heart Fail，2018，6（12）：975-982. studies［J］. Eur J Epidemiol，2018，33（8）：711-722. DOI：
DOI：10.1016/j.jchf.2018.09.006. 10.1007/s10654-017-0353-9.
［45］PANDEY A，LAMONTE M，KLEIN L，et al. Relationship ［57］SHAHREYAR M，DANG G，WAQAS BASHIR M，et al.
between physical activity，body mass index，and risk of heart Outcomes of in-hospital cardiopulmonary resuscitation in morbidly
failure［J］. J Am Coll Cardiol，2017，69（9）：1129-1142. obese patients［J］. JACC：Clin Electrophysiol，2017，3（2）：
DOI：10.1016/j.jacc.2016.11.081. 174-183. DOI：10.1016/j.jacep.2016.08.011.
［46］BOZKURT B，AGUILAR D，DESWAL A，et al. Contributory ［58］WONG C X，SULLIVAN T，SUN M T，et al. Obesity and the risk
risk and management of comorbidities of hypertension，obesity， of incident，post-operative，and post-ablation atrial fibrillation：
diabetes mellitus，hyperlipidemia，and metabolic syndrome in a meta-analysis of 626，603 individuals in 51 studies［J］. JACC
chronic heart failure：a scientific statement from the American Clin Electrophysiol，2015，1（3）：139-152. DOI：10.1016/j.
heart association［J］. Circulation，2016，134（23）. DOI： jacep.2015.04.004.
10.1161/cir.0000000000000450. ［59］TSANG T S M，BARNES M E，MIYASAKA Y，et al. Obesity as
［47］LAVIE C J，LADDU D，ARENA R，et al. Reprint of：healthy a risk factor for the progression of paroxysmal to permanent atrial
weight and obesity prevention：JACC health promotion series［J］. fibrillation：a longitudinal cohort study of 21 years［J］. Eur Heart J，
J Am Coll Cardiol，2018，72（23 Pt B）：3027-3052. DOI： 2008，29（18）：2227-2233. DOI：10.1093/eurheartj/ehn324.
10.1016/j.jacc.2018.10.024. ［60］WONG C X，SUN M T，ODUTAYO A，et al. Associations
［48］EMAMI A，SAITOH M，VALENTOVA M，et al. Comparison of of epicardial，abdominal，and overall adiposity with atrial
sarcopenia and cachexia in men with chronic heart failure：results fibrillation［J］. Circ：Arrhythmia Electrophysiol，2016，9（12）.
from the Studies Investigating Co-morbidities Aggravating Heart DOI：10.1161/circep.116.004378.
Failure （SICA-HF）［J］. Eur J Heart Fail，2018，20（11）： ［61］ABED H S，WITTERT G A，LEONG D P，et al. Effect of weight
1580-1587. DOI：10.1002/ejhf.1304. reduction and cardiometabolic risk factor management on symptom
［49］GHOSH R K，GHOSH G C，GUPTA M，et al. Sodium burden and severity in patients with atrial fibrillation［J］. JAMA，
glucose Co-transporter 2 inhibitors and heart failure［J］. Am 2013，310（19）：2050. DOI：10.1001/jama.2013.280521.
J Cardiol，2019，124（11）：1790-1796. DOI：10.1016/j. ［62］PATHAK R K，MIDDELDORP M E，MEREDITH M，et al.
amjcard.2019.08.038. Long-term effect of goal-directed weight management in an atrial
［50］JORSAL A，KISTORP C，HOLMAGER P，et al. Effect of fibrillation cohort：a long-term follow-up study （LEGACY）［J］.
liraglutide，a glucagon-like peptide-1 analogue，on left ventricular J Am Coll Cardiol，2015，65（20）：2159-2169. DOI：
function in stable chronic heart failure patients with and without 10.1016/j.jacc.2015.03.002.
diabetes （LIVE） —a multicentre，double-blind，randomised， （收稿日期：2021-08-24；修回日期：2021-10-26）
placebo-controlled trial［J］. Eur J Heart Fail，2017，19（1）： （本文编辑：贾萌萌）